Growth-factor and kinase signaling
BPC-157’s reputation rests on healing: tendons, ligaments, gut, skin. But healing is just biology, and biology runs on…
The signaling behind the healing claims
BPC-157’s reputation rests on healing: tendons, ligaments, gut, skin. But healing is just biology, and biology runs on cell signaling. This unit opens the three best-characterized signaling stories behind the claims, from a clean kinase cascade in tendon cells, to a cooperative trick with growth hormone, to a brand-new and unproven idea that might unify them all.
Two things to hold onto: the strongest of these findings still come from cell culture, not humans, and the most exciting of them, the SH3 / Src-kinase model, is a hypothesis-grade preprint. We label the confidence on every step so the elegant ideas never get mistaken for settled facts.
Key terms
FAK and paxillin: the cleanest link
The cleanest mechanistic story in the BPC-157 literature lives inside the tendon fibroblast. Chang and colleagues exposed these cells to BPC-157 and watched two proteins light up: focal adhesion kinase (FAK) and paxillin. Both gained phosphate groups in a dose-dependent way, the cells remodeled their focal adhesions faster, and they crawled toward the wound. This sequence, exposure to migration, is the tightest link the field has from molecule to repair.
Powerful but preclinical: these are cultured-cell readouts, dose-dependent and clean, yet still not replicated in human tendon cells as of 2026.
AdvancedFAK and Src are already partners
FAK autophosphorylation at Y397 builds the very docking site Src binds, and the FAK-Src complex is what phosphorylates paxillin. That detail matters later: if BPC-157 acts upstream on Src itself (the SH3 hypothesis), the FAK-paxillin signal you see here could be a downstream readout of the same event.